Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT)

Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
Thomas ZellerHans Krankenberg

Abstract

To investigate the impact of nitinol stenting of superficial femoral artery (SFA) lesions with a maximum length of 10 cm (TASC-II A or B) on 1-year outcomes compared to a historical study cohort from the Femoral Artery Stent Trial (FAST). Between January 2004 and August 2005, 6 study sites enrolled 110 symptomatic patients (75 men; mean age 68+/-9 years) with a single de novo >70% SFA lesion <10 cm long treated with the self-expanding nitinol Conformexx stent. The primary study endpoint was binary restenosis determined by duplex ultrasound at 12 months. Secondary 12-month endpoints were target lesion revascularization (TLR), ankle-brachial index (ABI), mean Rutherford category, >1-class change in Rutherford category, and major adverse events. Data were analyzed according to the intention-to-treat principle and according to the actual treatment received ("on treatment" analysis). Outcomes were compared to the historical balloon angioplasty (BA) arm and the Luminexx 3 stent arm of the randomized FAST study. Technical success was achieved in 106 (96%) patients; at 1 year, the primary endpoint of ultrasound-assessed binary restenosis was reached in 14 (23.3%) of 60 patients (95% CI 13.4% to 36%). This restenosis rate was lower vers...Continue Reading

References

Oct 6, 1997·Journal of Vascular Surgery·R B RutherfordD N Jones
Jun 5, 2001·Journal of Vascular and Interventional Radiology : JVIR·K KandarpaW J Landow
Apr 9, 2004·Techniques in Vascular and Interventional Radiology·Mark W Mewissen
Jan 18, 2005·Journal of the American College of Cardiology·Dierk ScheinertAndrej Schmidt
May 5, 2006·The New England Journal of Medicine·Martin SchillingerErich Minar
Oct 19, 2006·Journal of the American College of Cardiology·Thomas ZellerFranz-Josef Neumann
Dec 13, 2006·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Stephan H DudaJean-Paul Beregi
Feb 21, 2007·European Journal of Applied Physiology·Timothy A BauerWilliam R Hiatt

❮ Previous
Next ❯

Citations

Mar 4, 2014·Journal of Atherosclerosis and Thrombosis·Yoshimitsu SogaHiroki Takahashi
Aug 28, 2015·Journal of Atherosclerosis and Thrombosis·Norihiro KobayashiToshiya Muramatsu
Mar 29, 2014·Clinical Anatomy : Official Journal of the American Association of Clinical Anatomists & the British Association of Clinical Anatomists·Brion Benninger
Mar 29, 2011·Annals of Vascular Surgery·Peter GillgrenDavid Lindström
Mar 23, 2011·Journal of Vascular and Interventional Radiology : JVIR·Michael D DakeAnthony O Ragheb
Aug 12, 2009·Current Problems in Cardiology·Suhail AllaqabandTanvir Bajwa
Aug 2, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Yoshimitsu SogaMasakiyo Nobuyoshi
Sep 3, 2013·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Moshe VardiRobert W Yeh
Apr 18, 2014·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Konstantinos MarmagkiolisMehmet Cilingiroglu
Apr 29, 2014·Journal of Vascular and Interventional Radiology : JVIR·Jon C GeorgeRichard Kovach
Apr 24, 2014·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·John R LairdUNKNOWN Complete SE Investigators
Dec 6, 2012·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Karl-Ludwig SchulteRalf Langhoff
Oct 14, 2011·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Michael D DakeUNKNOWN Zilver PTX Single-Arm Study Investigators
Dec 14, 2011·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Dierk ScheinertAndrej Schmidt
Dec 12, 2013·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Martin WernerDierk Scheinert
Sep 13, 2011·Journal of Vascular Surgery·Bibombe P MwipatayiUNKNOWN Covered Versus Balloon Expandable Stent Trial (COBEST) Co-investigators
Jan 15, 2016·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Yoshimitsu SogaKenji Ando
Jan 25, 2018·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Luis M PalenaMarco Manzi
May 15, 2015·Circulation. Cardiovascular Interventions·Lawrence GarciaUNKNOWN SUPERB Trial Investigators
Jul 25, 2009·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Mark W Mewissen
Dec 10, 2009·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Thomas ZellerDierk Scheinert
Mar 13, 2015·Expert Review of Cardiovascular Therapy·Alessandro CannavaleMiltiadis Krokidis
May 1, 2018·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Yoshimitsu SogaUNKNOWN STOP-IC investigators
Nov 20, 2016·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Luis M PalenaMarco Manzi
Jul 28, 2018·Interactive Cardiovascular and Thoracic Surgery·Shahab HajibandehGeorge A Antoniou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.